SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?


To: macker who wrote (1317)6/18/1998 9:00:00 PM
From: Turboe  Respond to of 5402
 
Is the 30mm bigger than my 9mm? Blood and guns...Hmmmm....synergy...



To: macker who wrote (1317)6/18/1998 10:23:00 PM
From: Andrew H  Read Replies (2) | Respond to of 5402
 
Appreciate the civility, macker. It sure would be nice if the company would announce that 30M has been committed as part of an umbrella package. Since they are a BB stock, they automatically lack full credibility and 30M would certainly give them that.

The market for substitute blood products/oxygen carriers is gigantic and no satisfactory product has yet been approved so it is not unthinkable SGNC would get bought out or financed by a larger company as happened with Somatogen. However, I think they would at least need to complete P1 before that was likely to happen.

I will have to see what chirodoc posts about Batelle since I am not familiar with them.